Current Projects

Current Projects

REACHnet’s main project components focus on our technology, the CDRN’s governance, patient recruitment, provider engagement, and patient centered research. This informs our partners collaborating on study protocols, and engaging patients and clinicians in research topic generation and prioritization. Overall, we look to improve health outcomes and patient experiences, while executing the PCORnet national research agenda.

Adaptable: The Aspirin Study
10 March, 2016

Adaptable: The Aspirin Study

PCORnet study comparing aspirin maintenance dosage for the prevention of repeat coronary events in tandem with evaluating adverse gastrointestinal events. This trial will take place in cardiology clinics through use of the PTAS.

PCORnet study comparing aspirin maintenance dosage for the prevention of repeat coronary events in tandem with evaluating adverse gastrointestinal events. This trial will take place in cardiology clinics through use of the PTAS.

Learn More
The Natural Experiments Network (NEN)
9 March, 2016

The Natural Experiments Network (NEN)

NEN is a study REACHnet is involved in that was funded in 2016, and has a project period that lasts for the next five years. This study focuses on collaboration in diabetes management through non-face-to-face care coordination to enhance outcomes. This is a patient focused study and has constant engagement with patients and

NEN is a study REACHnet is involved in that was funded in 2016, and has a project period that lasts for the next five years. This study focuses on collaboration in diabetes management through non-face-to-face care coordination to enhance outcomes. This is a patient focused study and has constant engagement with patients and stakeholders in every step of the process. REACHnet is leveraging our Diabetes Advisory Group (DAG) to maximize the effectiveness of this research.

Learn More
Health in Our Hands
14 October, 2015

Health in Our Hands

REACHnet is piloting the PTAS in six clinical sites. Patients are given tablets at the point of care during their routine clinical visits. They are given information about HiOH and given the opportunity to consent into the network. To see projects HiOH members have been invited to, click here.

REACHnet is piloting the PTAS in six clinical sites. Patients are given tablets at the point of care during their routine clinical visits. They are given information about HiOH and given the opportunity to consent into the network. To see projects HiOH members have been invited to, click here.

Learn More